Lifestyle Before Medication

A pharmacist's perspective on health and metabolic disease

Should we use PCSK9 inhibitors?

I’ve just been asked about PCSK9 inhibitors. ┬áThese “Pesky” medications, which include the agents Alirocumab and Evolocumab, lower LDL cholesterol by inactivating a protein in the liver called called proprotein … Continue reading

August 10, 2016 · 6 Comments

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 658 other followers